1-12 of 12
Juying Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Dual CK1ε/PI3Kδ Inhibitor HZ-H08905 in Adult Patients with Relapsed and/or Refractory Hematologic Malignancies

Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Miao Hu, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4428.
https://doi.org/10.1182/blood-2023-185363
Published: 2023
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Feng Zhu, Nianci Chen, Yile Zhou, Yi Zhang, Jian Huang, Wanzhuo Xie, Haitao Meng, Wen-Juan Yu, Liping Mao, Wenyuan MAI, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6001.
https://doi.org/10.1182/blood-2023-186048
Published: 2023
Journal Articles

Small-Dose Trimethoprim-Sulfamethoxazole Prevents Pneumocystis Jiroveci Pneumonia in B-Cell Lymphoma Patients Receiving Chemotherapy: Analysis of a Randomized Controlled Clinical Trial

Chunxiao Liu, Xuewu Zhang, Yanan Zhu, Feng Xiao, Yunfei Lv, Xingnong Ye, Xia Li, Juying Wei, Huafeng Wang, Yile Zhou, Hongyan Tong, Xinping Zhou, Chunmei Yang, Liping Mao, De Zhou, Li Zhu, Xiaolong Zheng, Li Ye, Liangshun You, Jie Jin, Wenjuan Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6314.
https://doi.org/10.1182/blood-2023-189933
Published: 2023
Journal Articles

Chidamide As Maintenance in Peripheral T-Cell Lymphoma for Patients in Response after Induction Therapy: A Single Center Retrospective Study

Yanan Zhu, Juying Wei, Chunmei Yang, Wanzhuo Xie, Yanhong Tong, Wen-Juan Yu, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6183.
https://doi.org/10.1182/blood-2023-180495
Published: 2023
Journal Articles

Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia

Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Huang Li, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hongyan Tong, Jie Jin, Huafeng Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5926.
https://doi.org/10.1182/blood-2023-182806
Published: 2023
Journal Articles

Dual CK1ε/PI3Kδ Inhibitor HZ-H08905, Exhibits As a Potential Therapeutic Strategy for Hematologic Malignancies

Juying Wei, Wenjuan Yu, Hongyan Tong, Min Yang, Miao Hu, Xingguo Liu, Yizhe Wu, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 12065.
https://doi.org/10.1182/blood-2022-165195
Published: 2022
Journal Articles

Tucidinostat Maintenance after Achieving Objective Response to First-Line Therapy in Peripheral T-Cell Lymphoma: A Single-Center Retrospective Case-Control Study

Yanan Zhu, Wenjuan Yu, Jie Jin, Juying Wei, Hongyan Tong, Chunmei Yang, Xia Li, Wanzhuo Xie
Journal: Blood
Blood (2022) 140 (Supplement 1): 3694–3695.
https://doi.org/10.1182/blood-2022-163186
Published: 2022
Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

De Zhou, Xianbo Huang, Xueying Li, Lixia Zhu, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Xiudi Yang, Jianai Sun, Li Li, Wanzhuo Xie, Hongyan Tong, Jie Jin, Honghu Zhu, Xiujin Ye
Journal: Blood
Blood (2022) 140 (Supplement 1): 2620–2621.
https://doi.org/10.1182/blood-2022-164496
Published: 2022
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2334.
https://doi.org/10.1182/blood-2021-153257
Published: 2021
Journal Articles

Epigenetic Priming with Decitabine Followed By Low-Dose Idarubicin Plus Cytarabine in AML Evolving from MDS or Higher Risk MDS: A Multicentre Phase 2 Single-Arm Trial

Hongyan Tong, Docter, Xinping Zhou, Chen Mei, Jin Zhang, Ying Lu, Jianping Lan, MD, Shengyun Lin, Yuefeng Zhuang, Yuemin Kuang, Yanling Ren, Liya Ma, Juying Wei, Li Ye, Weilai Xu, Kongfei Li, Chenxi Lu, Jie Jin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2594.
https://doi.org/10.1182/blood-2019-127675
Published: 2019
Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Jinghan Wang, PhD, Zhixin Ma, PhD, Qinrong Wang, Mengxia Yu, PhD, Xiufeng Yin, PhD, Xia Li, PhD, Shanshan Suo, Dan Shen, Yungui Wang, PhD, Xin Huang, Hanzhang Pan, Huanping Wang, Zhimei Chen, MD, Jiansong Huang, PhD, Liping Mao, Wenjuan Yu, MD, Juying Wei, MD, Wenbin Qian, Wenyuan Mai, MD, Haitao Meng, MD, Hongyan Tong, MD, Suning Chen, Guido Marcucci, MD, Saijuan Chen, Jie Jin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5058.
https://doi.org/10.1182/blood.V128.22.5058.5058
Published: 2016